Back to Market Feed

IMATINIB MESYLATE 400 MG TAB

IMATINIB MESYLATE
$3.0339per EA

Strength

400 mg/1

NDC

31722029730

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

IMATINIB MESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA212975

On Market Since

4/14/2025

Pharmacological Classes

Bcr-Abl Tyrosine Kinase Inhibitors
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A4 Inhibitors
Kinase Inhibitor

Price History

1W

0.0%

1M

-5.5%

3M

-4.8%

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

-4.8%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

SERTRALINE HCL 25 MG TABLET
Generic
00904692461•Major Pharmaceuticals
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16714061101•NorthStar Rx LLC
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16714061104•NorthStar Rx LLC
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16714061105•NorthStar Rx LLC
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16714061106•NorthStar Rx LLC
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16729021515•Accord Healthcare Inc.
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
16729021516•Accord Healthcare Inc.
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
23155075705•Heritage Pharmaceuticals Inc.
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
23155075709•Heritage Pharmaceuticals Inc.
$0.0300
per EA
SERTRALINE HCL 25 MG TABLET
Generic
31722014505•Camber Pharmaceuticals Inc.
$0.0300
per EA